Get to know ABRYSVO

ABRYSVO is a vaccine that can help prevent disease of the lower respiratory tract (lungs) caused by RSV (respiratory syncytial virus). It is given to pregnant individuals during the third trimester (from 32 through 36 weeks’ gestation) to help protect their babies from birth through 6 months of age.

As with any vaccine, ABRYSVO will not protect 100% of those who receive it. ABRYSVO is not a treatment for RSV infection or its complications.

style
Heading-section, get-know

How ABRYSVO can help protect your baby

You will receive one dose of the ABRYSVO vaccine in your arm in your third trimester (when you are 32–36 weeks pregnant).
The vaccine works by helping your body to make the antibodies (the substances your body uses to fight an infection) that help protect against this disease.
These antibodies are then passed to your baby through your placenta before birth (a process called passive immunization). This helps protect your baby when they are the most vulnerable to RSV.
Note that ABRYSVO does not contain an adjuvant (a substance added to some vaccines to help the body produce an immune response).
style
Card-slider, Slider-readmore, desktop-carousel, half-width-carousel
pregnant woman
pregnant woman

Appointment timeline during pregnancy

Appointment timeline during pregnancy

Where ABRYSVO fits in your pregnancy

You will have many important appointments during your pregnancy, including an ultrasound when you are 18–22 weeks pregnant and a gestational diabetes screening when you are 24–28 weeks pregnant.

ABRYSVO is given when you are 32 through 36 weeks pregnant.

When your pregnancy care provider schedules your screening appointments, ask about scheduling your ABRYSVO vaccine as well.

Set a reminder

What are the possible side effects of ABRYSVO?

style
Needle, gtk, heading-sec

pregnant woman icon pink

ABRYSVO was given to

3,682

pregnant participants in its Phase 3 trial

Among the pregnant participants, the most common side effects were pain where the injection was given, headache, and muscle pain.

No side effects were reported in babies born to vaccinated mothers.

Like all vaccines, ABRYSVO can cause side effects, although not everyone experiences them.

Be sure to tell your healthcare professional if you have known allergies to any of the following substances: mannitol, polysorbate 80, sodium chloride, sucrose, tromethamine, trometamol hydrochloride.

Everything you need to know about ABRYSVO.

Download the information brochure

brochure cover thumbnail

brochure cover thumbnail

RSV in babies

About maternal vaccination

style
Button-group

ABRYSVO is a vaccine to help prevent disease of the lower respiratory tract (lungs) caused by RSV (respiratory syncytial virus). ABRYSVO is given to pregnant individuals (from 32 through 36 weeks’ gestation) to protect their infants from birth through 6 months of age, and individuals 60 years of age and older. As with any vaccine, ABRYSVO will not protect 100% of those who receive it. ABRYSVO is not a treatment for RSV infection or its complications. Like all vaccines, ABRYSVO can cause side effects, although not everybody gets them.

For more information, please consult the Product Monograph or call 1-800-463-6001.

ABRYSVO for adults 60+